XML 46 R18.htm IDEA: XBRL DOCUMENT

License Agreement	12 Months Ended
Dec. 31, 2012
Significant Agreements Disclosure [Abstract]
License Agreement	Note 12: License Agreement The Company is the exclusive licensee through the Massachusetts General Hospital of U.S. Patent number 5,843,000 entitled, “Optical Biopsy Forceps and Method of Diagnosing Tissue” and a pending international patent application. This license agreement requires a royalty be paid on sales of the patent on products using claims described within the patent under the license as well as patent expansion and annuities required to maintain the patent. During the fiscal year ended December 31, 2012, the Company paid Massachusetts General Hospital approximately $9,000 in fees related to this patent.

License Agreement

12 Months Ended

Dec. 31, 2012

Significant Agreements Disclosure [Abstract]

Note 12: License Agreement

The Company is the exclusive licensee through the Massachusetts General Hospital of U.S. Patent number 5,843,000 entitled, “Optical Biopsy Forceps and Method of Diagnosing Tissue” and a pending international patent application. This license agreement requires a royalty be paid on sales of the patent on products using claims described within the patent under the license as well as patent expansion and annuities required to maintain the patent. During the fiscal year ended December 31, 2012, the Company paid Massachusetts General Hospital approximately $9,000 in fees related to this patent.